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Objective: Diagnosis of pulmonary embolism (PE) remains difﬁ  cult and is often missed in 
the elderly due to nonspeciﬁ  c and atypical presentation. Diagnostic algorithms able to rule out 
PE and validated in young adult patients may have reduced applicability in elderly patients, 
which increases the number of diagnostic tools use and costs. The aim of the present study was 
to analyze the reported clinical presentation of PE in patients aged 65 and more.
Materials and Methods: Prospective and retrospective English language studies dealing with 
the clinical, instrumental and laboratory aspects of PE in patients more than 65 and published 
after January 1987 and indexed in MEDLINE using keywords as pulmonary embolism, elderly, 
old, venous thromboembolism (VTE) in the title, abstract or text, were reviewed.
Results: Dyspnea (range 59%–91.5%), tachypnea (46%–74%), tachycardia (29%–76%), and 
chest pain (26%–57%) represented the most common clinical symptoms and signs. Bed rest 
was the most frequent risk factor for VTE (15%–67%); deep vein thrombosis was detected 
in 15%–50% of cases. Sinus tachycardia, right bundle branch block, and ST-T abnormalities 
were the most frequent ECG ﬁ  ndings. Abnormalities of chest X-ray varied (less than 50% in 
one-half of the studies and more than 70% in the other one-half). Arterial blood gas analysis 
revealed severe hypoxemia and mild hypocapnia as the main ﬁ  ndings. D-Dimer was higher 
than cut-off in 100% of patients in 75% of studies. Clinical usefulness of D-Dimer measure-
ment decreases with age, although the strategies based on D-Dimer seem to be cost-effective 
at least until 80 years.
Conclusion: Despite limitations due to pooling data of heterogeneous studies, our review 
could contribute to the knowledge of the presentation of PE in the elderly with its diagnostic 
difﬁ  culties. A diagnostic strategy based on reviewed data is proposed.
Keywords: pulmonary embolism, diagnosis, elderly, symptoms
Introduction
Despite modern guidelines, ruling out or diagnosing pulmonary embolism (PE) 
represents one of the main medical problem in clinical geriatric practice (Rogers 
2007). PE remains in fact an under-diagnosed disease in old people, even though its 
incidence, prevalence, morbidity, and mortality increase steadily with age (Knifﬁ  n 
et al 1994; Hansson et al 1997; Silverstein et al 1998; Goldhaber et al 1999; Heit 
et al 1999; White 2003; Stein et al 2004). It has been reported that PE represented the 
main cause of death that is less suspected by physicians in the elderly (Leibovitz et al 
2001). About 40% of PE found at necropsy in older persons were not suspected ante 
mortem (Leibovitz et al 2001).
The diagnostic process of PE starts from clinical suspicion both in young adults and 
in elderly patients (Tapson et al 1999; ESC 2000; ACEP 2003; BTS 2003; Goldhaber 
and Elliott 2003; Stein et al 2006). Assessment of clinical probability represents the ﬁ  rst 
step to reach a prompt diagnosis of PE and to prevent delays in the diagnostic work-up 
and initiation of appropriate treatment. Assessment of clinical probability derives from 
an integration of history, analysis of risk factors for venous thromboembolism (VTE), Vascular Health and Risk Management 2008:4(3) 630
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symptoms and signs with ﬁ  rst level investigations such as 
systolic blood pressure, 12-leads electrocardiography (ECG), 
chest X-ray, and arterial blood gas analysis (ABG). Clinical 
pre-test probability (PTP) should be evaluated by using one 
of the available and validated score, such as the Wells’ score 
or the Geneva score (Wells et al 1998; Tapson et al 1999; 
ESC 2000; ACEP 2003; BTS 2003; Goldhaber and Elliott 
2003; Le Gal et al 2006; Stein et al 2006). After assessment 
of clinical probability, D-Dimer measurement is often the 
next proposed step in diagnostic strategies for suspected 
PE (Stein et al 2004). However, D-Dimer assay should be 
performed only in nonhigh PTP (low or moderate PTP) (BTS 
2003). PE may be ruled out when nonhigh PTP is associated 
to negative D-Dimer (500 µg/L) (Tapson et al 1999; ESC 
2000; ACEP 2003; BTS 2003; Goldhaber and Elliott 2003; 
Perrier et al 2005; Christopher Study Investigators 2006; 
Stein et al 2006). In the other cases, PE should be conﬁ  rmed 
with helical pulmonary angio-computer tomography (angio-
CT), preferably multidetector type, lung scan or pulmonary 
angiography (Tapson et al 1999; ESC 2000; ACEP 2003; 
BTS 2003; Goldhaber and Elliott 2003; Stein et al 2006). 
The use of lung scan for conﬁ  rming PE has been reduced 
because of the major availability of helical angio-CT, and 
in reason of the important proportion of inconclusive lung 
scan, in particular in elderly patients. Legs ultrasonography 
is noninvasive, and is able to detect deep vein thrombosis 
(DVT). The presence of a recent DVT is enough to rule in 
the diagnosis of PE and DVT and start anticoagulation (Le 
Gal et al 2006). Combination of PTP with different levels 
of D-Dimer could reduce the number of unnecessary legs 
ultrasonography for ruling out DVT in patients with symp-
tomatic PE (Yamaki et al 2007). Trans thoracic echocardio-
gram (TTE), is particularly useful in suspected massive PE, 
when unstability of patient precludes complicated diagnostic 
algorithms. Moreover it could offer information for prognosis 
stratiﬁ  cation and aid the choice of treatment, as biomarkers 
(B natriuretic peptides and cardiac troponins) (Tapson et al 
1999; ESC 2000; Goldhaber 2002; ACEP 2003; BTS 2003; 
Goldhaber and Elliott 2003; Kucher et al 2003; Pieralli et al 
2006; Stein et al 2006; Becattini et al 2007).
Since the evidence showed difﬁ  culties in diagnosing of 
PE in the elderly, the clinical, instrumental and laboratory 
presentation of PE in elderly patients are reviewed in the 
present article.
Sources were obtained from articles indexed in 
MEDLINE database from January 1987 to August 2007 
searching terms “pulmonary embolism”, “elderly”, “old”, 
“venous thromboembolism” in the title, abstract and/or 
text. Additional references were identiﬁ  ed by reviewing 
the bibliographies of retrieved articles. Only prospective 
and retrospective English language studies dealing with the 
clinical, instrumental and/or laboratory presentation of PE 
patients aged more than 65 years were considered for the 
review. Studies were included if they reported patients with 
conﬁ  rmed PE. We did not perform a systematic review, but 
we reported data of more relevant articles.
Results
Symptoms, risk factors of   VTE, ﬁ  rst line 
instrumental examinations, and arterial 
blood gas analysis (ABG)
These data derived from twelve selected articles (Busby 
et al 1988; Stein et al 1991; Jones et al 1993; Gisselbrcht 
et al 1996; Masotti et al 2000; Ramos et al 2000; Ceccarelli et al 
2003; Timmons et al 2003; Kokturk et al 2005; Le Gal et al 
2005; Punukollu et al 2005; Chung et al 2006). From ten of 
them, we derived data for acute mortality, symptoms, signs 
and risk factors for VTE (Busby et al 1988; Stein et al 1991; 
Gisselbrcht et al 1996; Masotti et al 2000; Ramos et al 2000; 
Ceccarelli et al 2003; Timmons et al 2003; Kokturk et al 2005; 
Le Gal et al 2005; Punukollu et al 2005); from seven articles we 
derived data for 12-leads ECG (Stein et al 1991; Masotti et al 
2000; Ramos et al 2000; Ceccarelli et al 2003; Timmons et al 
2003; Kokturk et al 2005), from six data for chest X-ray (Busby 
et al 1988; Stein et al 1991; Masotti et al 2000; Ramos et al 
2000; Ceccarelli et al 2003; Le Gal et al 2005), from four data 
for TTE and from seven data for ABG (Stein et al 1991; Jones 
et al 1993; Gisselbrcht et al 1996; Masotti et al 2000; Ramos 
et al 2000; Ceccarelli et al 2003; Kokturk et al 2005).
Dyspnea (range 59%–91.5%), tachypnea (46%–74%), 
tachycardia (29%–76%), and chest pain (range 26%–59%) rep-
resented the main symptoms reported in clinical studies about 
PE in the elderly. Bed rest (range 15%–67%) and DVT (range 
15%–50%) were the main risk factors for VTE (Table 1).
Sinus tachycardia (range 18%–62.5%), right bundle 
branch block (4.5%–40.5%) and ST-T abnormalities 
(9%–37%) were the most represented 12-leads-ECG 
ﬁ  ndings; the typical S1Q3/S1Q3T3 ECG pattern was found 
in 4.5%–14% of patients.
Three studies reported abnormalities in less of one half 
of patients at chest X-ray (Busby et al 1988; Ramos et al 
2000; Le Gal et al 2005) while in other three studies more 
than 70% of patients had abnormalities (Stein et al 1991; 
Masotti et al 2000; Ceccarelli et al 2003). Cardiomegaly 
(range 22%–64%), pleural effusion (15.8%–57%), and Vascular Health and Risk Management 2008:4(3) 631
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Table 2 12-leads electrocardiography, chest X-ray, arterial blood gas analysis ﬁ  ndings
12-leads ECG
Reference Year Stein
1991
Ramos 
2000
Masotti
2003
Ceccarelli 
2003
Timmons 
2003
Kokturk 
2005
Tot./Range 
(1988–2005)
Normal 21% nr nr nr nr 50% (21%–50%)
Sinus tachycardia nr nr 60% 62.5% 18% nr (18%–62.5%)
Atrial ﬁ  brillation nr 20% 20% 20.5% 7% 13.6% (7%–20.5%)
RBBB 9% 9% 27% 40.5% 18% 4.5% (4.5%–40.5%)
S1Q3/S1Q3T3T3 nr 8% 12% 8.5% 14% 4.5% (4.5%–14%)
ST-T abnormalities 56% 22% 34% 51% 4% 13.6% (4%–56%)
Chest X-ray
Reference Busby Stein Ramos Masotti Ceccarelli Le Gal Tot./Range
Year 1988 1991 2000 2003 2003 2005 (1988–2005)
Abnormal 38% 96% 43% 80.5% 86.5% nr (38%–96%)
Cardiomegaly nr 22% 20% 58% 64% nr (22%–64%)
Pulmonary edema nr 13% nr 13.5% 30.5% nr (13%–30.5%)
Pleural effusion 16% 57% nr 18% 17% 15.8% (15.8%–57%)
Atelectasis 22% 71% 14% 15% 8.5% 14% (8.5%–71%)
Hemidiaphragm nr 28% nr nr 8.5% 18.2% (8.5%–28%)
elevation
ABG
Reference Stein Jones Gisselbrecht Ramos Masotti Ceccarelli Kokturk Tot./Range
Year 1991 1993 1996 2000 2003 2003 2005 (1988–2005)
Mean paO2(mmHg) 61 ± 12 61.4 55 ± 9 60 ± 10 54.6 ± 14.7 53.5 ± 15.4 59.5 ± 9.8 (53.5–61.4)
Mean paCO2(mmHg) nr nr 30 ± 5 33 ± 5 41.7 ± 15 42.1 ± 16.5 32.9 ± 9.8 (30–42.1)
Mean [D(A-a)O2] (mmHg) nr 46.6 nr nr 45.3 ± 22.4 44.8 ± 21.6 nr (44.8–46.6)
Abbreviations: paO2, oxygen arterial partial pressure; paCO2, dioxide arterial partial pressure; D(A-a)O2, alveolar-arterial oxygen gradient; nr, not reported nr, not 
reported; RBBB, right bundle branch block.
(8.5%–71%) were the most frequent reported aspects. More 
than 50% of patients had features of right heart overload at 
TTE (Masotti et al 2000; Ceccarelli et al 2003; Kokturk et al 
2005; Chung et al 2006).
A severe hypoxemic respiratory failure was found as main 
ABG pattern. In ﬁ  ve studies, this pattern was associated to low 
arterial carbon dioxide partial pressure (PaCO2). In three studies 
the alveolar-arterial oxygen gradient, D(A-a)O2, was analyzed 
(Jones et al 1993; Masotti et al 2000; Ceccarelli et al 2003), and 
was found to be elevated (range 44.8–46.6 mmHg).
Table 2 summarizes the ﬁ  rst line instrumental ﬁ  ndings.
Pre-test clinical probability and D-Dimer
Two studies have analyzed the ﬁ  eld of applicability of PTP 
combined with D-Dimer for ruling out PE in the elderly (Righini 
et al 2004; Söhne et al 2005). These studies have reported that 
the percentage of high PTP increases in elderly compared to 
younger patients, whereas the percentage of low PTP decreases. 
One study suggested that Geneva score seemed to perform better 
in elderly patients compared to Wells score (Righini et al 2004). 
One of these studies has demonstrated that the sensitivity and 
negative predictive value of a combination of low PTP and 
negative D-Dimer were high in elderly patients. Unfortunately 
the prevalence of elderly having the association non high PTP-
negative D-Dimer is low (14% of age over than 75 years) (Söhne 
et al 2005). However a strategy combining PTP and D-Dimer is 
still cost-effectiveness at least until 80 years (Righini et al 2007).
The speciﬁ  city of D-Dimer in patients with suspected PE 
decreases steady with age. One study has demonstrated that the 
speciﬁ  city of ELISA D-Dimer (VIDAS, Biomerieux, France) in 
suspected VTE reduces from 70.5% in patients under 40 years to 
4.5% in patients over 80 years (Harper et al 2007). Similar speci-
ﬁ  city (5%) was found in another study in patients over 80 years 
with nonhigh PTP by using the same ELISA D-Dimer method 
(Righini et al 2000). The very low speciﬁ  city of D-Dimer in the 
elderly has led to suggest an increased cut-off value of D-Dimer. 
Two series have concluded that an increased cut-off of D-Dimer 
reduced the false positives but increased the percentage of false 
negatives. Conversely, another study has demonstrated that 
increasing the cut-off from 500 microg/L to 750 microg/L and 
1000 microg/L, led to a rise in D-Dimer speciﬁ  city in patients 
over 80 years (from 4.5% to 13.1% and 27.3%, respectively) 
without loss of sensibility (Aguilar et al 2001; Righini et al 2001; 
Harper et al 2007).Vascular Health and Risk Management 2008:4(3) 633
Pulmonary embolism in the elderly
One study (Masotti et al 2000) has shown that 86% of 
patients with PE had D-Dimer 500 µg/L measured with 
latex agglutination. In another study D-Dimer, measured by 
immunoturbidimetric method, was over the cut-off value in 
98.5% of patients (Söhne et al 2005). Four studies demon-
strated that all patients (100%) had D-Dimer values higher 
than cut-off (Tardy et al 1998; Barro et al 1999; Masotti et al 
2000; Ceccarelli et al 2003).
Instrumental examinations for conﬁ  rming PE
Two studies have analyzed the effect of age on the diagnostic 
performance of helical angio-CT to diagnose PE. Either by 
single detector or multidetector helical pulmonary angio-CT, 
the sensitivity, speciﬁ  city, positive, and negative predictive 
values are not inﬂ  uenced by age, making applicable and 
safe the diagnostic strategies based on these investigations 
(Righini et al 2004; Stein et al 2007).
In selected elderly patients without previous cardiopul-
monary diseases ventilation/perfusion (V/Q) lung scan has 
similar applicability in the elderly compared with younger 
patients (Stein et al 1996). In unselected patients, rate of non 
diagnostic lung scan is higher in elderly patients (Calvo-
Romero et al 2005). The diagnostic yield of lung scan 
decreases from 68% in patients under 40 years to 42% in the 
patients aged 80 years and older (Righini et al 2000).
Sensitivity of legs ultrasonography for detection of DVT 
increase with age, whereas speciﬁ  city does not change with 
age, close to 100% (Righini et al 2000).
Sensitivity and speciﬁ  city of pulmonary angiography 
remain similar to young adults but this procedure could be 
limited by higher risk of acute renal failure due to iodinate 
contrast (Stein et al 1991).
A recent meta-analysis on prognostic values of cardiac 
troponins has shown that elevated levels of troponins iden-
tify high risk patients for death and adverse outcomes, even 
though in the studies concerning patients with mean age 
65 years. (Giannitsis et al 2000; Enea et al 2004; Hsu et al 
2006; Kaczynska et al 2006; Becattini et al 2007). One study 
has evaluated the prognostic role of BNP in the elderly, and 
concluded that this biomarker was not a solid indicator of 
complicated PE (Ray et al 2006).
Discussion and implications 
for clinical practice
The two crucial questions about PE in the elderly are: in 
which patients should PE be suspected and searched for, and 
which diagnostic procedures and algorithms could be safely 
performed.
PE represents one of the main causes of acute respiratory 
failure (ARF) in the elderly patients. In a recent observational 
study on 514 elderly patients with ARF, 18% of them had 
conﬁ  rmed PE. An inappropriate initial treatment due to 
uncorrected diagnosis was associated to an increased mortal-
ity (Ray et al 2006). PE was one of the main causes incor-
rectly diagnosed (Ray et al 2006).
In elderly patients, making the difference between PE 
symptoms and other cardio-respiratory diseases such as 
congestive heart failure, pneumonia and/or COPD (chronic 
obstructive pulmonary disease) exacerbation could be very 
challenging because of the frequent similar clinical picture 
and coexistence of diseases (Ray et al 2006). As shown in 
the present study, the most frequent symptoms and signs of 
conﬁ  rmed PE in elderly patients are dyspnea, tachypnea, 
tachycardia, and chest pain. All these symptoms and signs 
are nonspeciﬁ  c and similar to that of PE in younger patients 
(PIOPED Investigators 1990; Miniati et al 1996; Goldhaber 
et al 1999). Chest pain seem to be less frequent and 
tachycardia and syncope more frequent in the elderly com-
pared with nonelderly patients (Busby et al 1988; Stein et al 
1991; Gisselbrcht et al 1996; Kokturk et al 2005; Punukollu 
et al 2005). Bed rest is the most frequent risk factors for PE 
in the elderly, together with surgery and cancer. Evident 
implication is that primary prophylaxis using mechanical 
or pharmacological measures should be carefully evaluated 
in elderly bedridden patients. (PIOPED Investigators 1990; 
Miniati et al 1996; Goldhaber et al 1999).
The speciﬁ  city of instrumental and laboratory examina-
tions is low both in elderly and nonelderly patients: 12-leads-
ECG, chest X-ray, and ABG do not increase the suspicion 
of PE in the elderly.
ABG could reveal an hypoxemic respiratory failure 
associated to normal or mildly reduced PaCO2 and increased 
D(A-a)O2 similarly to congestive heart failure and pneumo-
nia. It should be kept in mind that in two studies enrolling 
patients with previous cardio-pulmonary diseases, mean 
values of PaCO2 were in normal range. Only one third 
of patients had respiratory alkalosis (Masotti et al 2000; 
Ceccarelli et al 2003), suggesting an impaired response to 
acute stress in elderly patients. Compared with younger 
patients, ABG in elderly patients seems to reveal lower 
hypoxemia and higher values of alveolar-arterial oxygen 
gradient (PIOPED Investigators 1990).
The role of D-Dimer is well recognized to rule out PE 
when it is negative and associated to a non-high PTP. How-
ever, the speciﬁ  city and the clinical usefulness of D-Dimer 
decrease with age because of high percentage of elderly Vascular Health and Risk Management 2008:4(3) 634
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patients with D-Dimer higher than cut-off. Unfortunately 
increasing cut-off of D-Dimer could lead to increase the 
percentage of patients wrongly considered negatives, and is 
therefore considered unsafe.
Recently, the ﬁ  rst diagnostic algorithm, not validated, 
for suspected PE in the elderly has been reported (Righini 
et al 2005). The most important ﬁ  ndings of this diagnostic 
strategy are represented by the non invasivity of ﬁ  rst-line 
investigation (PTP evaluation, and legs ultrasonography), 
and angio-CT as conﬁ  rming examination. In this algorithm 
D-Dimer is not widely recommended; its assay should 
be reserved to selected conditions (limited availability of 
other diagnostic tests or presence of high risk of adverse 
reactions due to instrumental examinations with contrast). 
However, more recently the same Authors demonstrated 
that in elderly outpatients the strategies based on PTP 
evaluation, and D-Dimer assay are cost-effectiveness at 
least until 80 years and that strategies with legs ultraso-
nography are more expensive but not safer. Therefore, 
measuring D-dimer in outpatients more than 80 years may 
be differently appreciated. On one side, one could argue 
that the clinical usefulness is so limited that D-dimer 
measurement is not indicated. On the other side, D-dimer 
measurement does not increase the costs of diagnostic 
strategies. To avoid complicated recommendations or 
age-adapted diagnostic strategies (for example not dos-
ing D-dimer in elderly patients), a systematic measure-
ment may be proposed, at least in outpatients. Moreover, 
D-dimer might still be justiﬁ  ed in patients above 80 years 
when the availability of other diagnostic tests is limited 
or when the risk of imaging using hCT is higher because 
of impaired renal function.
Helical pulmonary angio-CT should be encouraged in 
the elderly since it has been proved to be safe and accurate 
in the oldest and since lung scan has limited accuracy in this 
subset of patients. (Stein et al 1996; Righini et al 2000, 2004; 
Calvo-Romero et al 2005; Stein et al 2007).
Figure 1 shows an algorithm for elderly patients with 
suspected PE derived from the most recent evidence of 
literature.
Limits of the study
We are aware of some limitations of our review. First we 
pooled data from heterogeneous studies with different 
methodology. This review was not systematic and could 
be scientifically subjected to criticism. Studies about 
diagnostic strategy for diagnosing PE in the elderly are 
lacking, and our conclusions are based upon small series. 
Table 3 summarizes the implications of this review in the 
clinical practice.
Conclusion
PE is a potentially life-threatening condition, difﬁ  cult to 
diagnose in elderly patients. Misdiagnosis is more frequent in 
the elderly patients Clinical signs of PE are neither sensitive 
nor speciﬁ  c enough to rule in or out the diagnosis. Our review 
suggests that PE should be suspected in any elderly patient 
at risk with unexplained dyspnea, tachypnea, or tachycardia. 
PE ruledout
D-Dimer Neg
PE ruledout
No PE
Treat
PE
PE ruledout
Non high PTP
Pulmonaryangiography
High PTP
Inconclusive
Multidetector CT
D-Dimer Pos
Non high PTP High PTP
<80 years
No DVT
Treat
DVT
Legsultrasonography
>80 years
Suspicion
PTP
Figure 1 Diagnostic algorithm for elderly patients with suspected PE derived from literature evidence.Vascular Health and Risk Management 2008:4(3) 635
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However these ﬁ  ndings are highly nonspeciﬁ  c, which reduces 
the diagnostic value.
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